BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Ordinary Shares, par value US$0.0001 per share
- Shares outstanding
- 37,379,062
- Total 13F shares
- 857,329
- Share change
- +742,241
- Total reported value
- $25,861,711
- Price per share
- $30.15
- Number of holders
- 7
- Value change
- +$22,306,675
- Number of buys
- 6
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07782B104:
Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atria Wealth Solutions, Inc. |
13F
|
Company |
0.15%
|
54,205
|
$1,818,578 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
18,308
|
$615,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
10,608
|
$359,000 | — | 30 Sep 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
10,442
|
$353,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
7,400
|
$250,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
7,264
|
$245,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
6,661
|
$223,000 | — | 30 Sep 2022 | |
| Prestige Wealth Management Group LLC |
13F
|
Company |
0%
|
200
|
$7,000 | — | 30 Sep 2022 |
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q4 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.